Agilon Health (AGL) Competitors

$57.78 +3.55 (+6.54%)

As of 02:53 PM Eastern

AGL vs. WGS, SGRY, ADUS, AHCO, and SNDA

Should you be buying Agilon Health stock or one of its competitors? The main competitors of Agilon Health include GeneDx (WGS), Surgery Partners (SGRY), Addus HomeCare (ADUS), AdaptHealth (AHCO), and Sonida Senior Living (SNDA). These companies are all part of the "healthcare" industry.

How does Agilon Health compare to GeneDx?

GeneDx (NASDAQ:WGS) and Agilon Health (NYSE:AGL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Agilon Health has a net margin of -6.09% compared to GeneDx's net margin of -17.58%. GeneDx's return on equity of 9.15% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GeneDx	-17.58%	9.15%	5.21%
Agilon Health	-6.09%	-146.03%	-24.55%

GeneDx currently has a consensus price target of $96.43, suggesting a potential upside of 146.15%. Agilon Health has a consensus price target of $37.93, suggesting a potential downside of 30.42%. Given GeneDx's stronger consensus rating and higher possible upside, research analysts clearly believe GeneDx is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GeneDx	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63
Agilon Health	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

61.7% of GeneDx shares are held by institutional investors. 29.6% of GeneDx shares are held by insiders. Comparatively, 2.3% of Agilon Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

GeneDx has higher earnings, but lower revenue than Agilon Health. GeneDx is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GeneDx	$427.54M	2.72	-$21.02M	-$2.68	N/A
Agilon Health	$5.93B	0.15	-$391.35M	-$21.56	N/A

In the previous week, GeneDx had 11 more articles in the media than Agilon Health. MarketBeat recorded 34 mentions for GeneDx and 23 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.40 beat GeneDx's score of -0.22 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GeneDx	2 Very Positive mention(s)	0 Positive mention(s)	18 Neutral mention(s)	7 Negative mention(s)	3 Very Negative mention(s)	Neutral
Agilon Health	7 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

GeneDx has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Comparatively, Agilon Health has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500.

Summary

GeneDx beats Agilon Health on 11 of the 16 factors compared between the two stocks.

How does Agilon Health compare to Surgery Partners?

Agilon Health (NYSE:AGL) and Surgery Partners (NASDAQ:SGRY) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations.

Surgery Partners has a net margin of -2.28% compared to Agilon Health's net margin of -6.09%. Surgery Partners' return on equity of 1.04% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Surgery Partners	-2.28%	1.04%	0.41%

Surgery Partners has lower revenue, but higher earnings than Agilon Health. Surgery Partners is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.15	-$391.35M	-$21.56	N/A
Surgery Partners	$3.34B	0.55	-$77.90M	-$0.60	N/A

In the previous week, Agilon Health had 8 more articles in the media than Surgery Partners. MarketBeat recorded 23 mentions for Agilon Health and 15 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.51 beat Agilon Health's score of 0.40 indicating that Surgery Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilon Health	7 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Surgery Partners	2 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilon Health currently has a consensus price target of $37.93, suggesting a potential downside of 30.42%. Surgery Partners has a consensus price target of $22.18, suggesting a potential upside of 59.00%. Given Surgery Partners' stronger consensus rating and higher probable upside, analysts plainly believe Surgery Partners is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
Surgery Partners	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.58

Agilon Health has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500. Comparatively, Surgery Partners has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500.

Summary

Surgery Partners beats Agilon Health on 10 of the 14 factors compared between the two stocks.

How does Agilon Health compare to Addus HomeCare?

Addus HomeCare (NASDAQ:ADUS) and Agilon Health (NYSE:AGL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

95.3% of Addus HomeCare shares are owned by institutional investors. 4.5% of Addus HomeCare shares are owned by company insiders. Comparatively, 2.3% of Agilon Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Addus HomeCare has a net margin of 6.89% compared to Agilon Health's net margin of -6.09%. Addus HomeCare's return on equity of 9.80% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.89%	9.80%	7.34%
Agilon Health	-6.09%	-146.03%	-24.55%

Addus HomeCare has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.45B	1.24	$95.91M	$5.41	17.82
Agilon Health	$5.93B	0.15	-$391.35M	-$21.56	N/A

In the previous week, Agilon Health had 1 more articles in the media than Addus HomeCare. MarketBeat recorded 23 mentions for Agilon Health and 22 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.52 beat Agilon Health's score of 0.40 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	6 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilon Health	7 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Addus HomeCare presently has a consensus price target of $132.33, suggesting a potential upside of 37.28%. Agilon Health has a consensus price target of $37.93, suggesting a potential downside of 30.42%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts plainly believe Addus HomeCare is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73
Agilon Health	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

Addus HomeCare has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500.

Summary

Addus HomeCare beats Agilon Health on 14 of the 17 factors compared between the two stocks.

How does Agilon Health compare to AdaptHealth?

AdaptHealth (NASDAQ:AHCO) and Agilon Health (NYSE:AGL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

AdaptHealth has a net margin of -2.42% compared to Agilon Health's net margin of -6.09%. AdaptHealth's return on equity of 2.76% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AdaptHealth	-2.42%	2.76%	0.99%
Agilon Health	-6.09%	-146.03%	-24.55%

AdaptHealth has higher earnings, but lower revenue than Agilon Health. AdaptHealth is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AdaptHealth	$3.28B	0.47	-$70.79M	-$0.62	N/A
Agilon Health	$5.93B	0.15	-$391.35M	-$21.56	N/A

82.7% of AdaptHealth shares are owned by institutional investors. 1.6% of AdaptHealth shares are owned by insiders. Comparatively, 2.3% of Agilon Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, AdaptHealth and AdaptHealth both had 23 articles in the media. Agilon Health's average media sentiment score of 0.40 beat AdaptHealth's score of 0.07 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AdaptHealth	5 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agilon Health	7 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

AdaptHealth presently has a consensus target price of $14.29, suggesting a potential upside of 26.50%. Agilon Health has a consensus target price of $37.93, suggesting a potential downside of 30.42%. Given AdaptHealth's stronger consensus rating and higher possible upside, equities research analysts plainly believe AdaptHealth is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AdaptHealth	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50
Agilon Health	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

AdaptHealth has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Comparatively, Agilon Health has a beta of 2.29, indicating that its stock price is 129% more volatile than the S&P 500.

Summary

AdaptHealth beats Agilon Health on 9 of the 14 factors compared between the two stocks.

How does Agilon Health compare to Sonida Senior Living?

Sonida Senior Living (NYSE:SNDA) and Agilon Health (NYSE:AGL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Sonida Senior Living has higher earnings, but lower revenue than Agilon Health. Sonida Senior Living is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonida Senior Living	$381.14M	4.56	-$70.78M	-$4.21	N/A
Agilon Health	$5.93B	0.15	-$391.35M	-$21.56	N/A

Sonida Senior Living has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 2.29, indicating that its stock price is 129% more volatile than the S&P 500.

In the previous week, Agilon Health had 18 more articles in the media than Sonida Senior Living. MarketBeat recorded 23 mentions for Agilon Health and 5 mentions for Sonida Senior Living. Agilon Health's average media sentiment score of 0.40 beat Sonida Senior Living's score of -0.31 indicating that Agilon Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sonida Senior Living	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agilon Health	7 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

87.6% of Sonida Senior Living shares are owned by institutional investors. 3.1% of Sonida Senior Living shares are owned by insiders. Comparatively, 2.3% of Agilon Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Sonida Senior Living presently has a consensus target price of $35.75, suggesting a potential downside of 2.54%. Agilon Health has a consensus target price of $37.93, suggesting a potential downside of 30.42%. Given Sonida Senior Living's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sonida Senior Living is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonida Senior Living	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Agilon Health	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

Agilon Health has a net margin of -6.09% compared to Sonida Senior Living's net margin of -18.57%. Agilon Health's return on equity of -146.03% beat Sonida Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonida Senior Living	-18.57%	-150.51%	-7.47%
Agilon Health	-6.09%	-146.03%	-24.55%

Summary

Sonida Senior Living and Agilon Health tied by winning 8 of the 16 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AGL vs. The Competition

Export

Metric	Agilon Health	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$907.58M	$8.19B	$6.20B	$22.94B
Dividend Yield	N/A	2.86%	2.78%	4.02%
P/E Ratio	-2.52	22.68	20.71	29.04
Price / Sales	0.15	16.42	549.99	24.71
Price / Cash	N/A	12.66	27.81	19.21
Price / Book	7.13	4.93	9.82	4.66
Net Income	-$391.35M	$183.43M	$3.55B	$1.07B
7 Day Performance	N/A	N/A	N/A	-0.81%
1 Month Performance	186.78%	7.54%	6.77%	4.28%
1 Year Performance	-24.03%	1.47%	42.65%	29.36%

Agilon Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AGL Agilon Health	1.5201 of 5 stars	$57.78 +6.5%	$37.93 -34.4%	-24.9%	$963.85M	$5.93B	N/A	1,076	Earnings Report Analyst Forecast
WGS GeneDx	4.0752 of 5 stars	$67.93 +3.9%	$134.17 +97.5%	-30.8%	$1.91B	$427.54M	N/A	1,300	Earnings Report Analyst Downgrade High Trading Volume
SGRY Surgery Partners	3.5432 of 5 stars	$14.20 -0.5%	$22.00 +54.9%	-35.0%	$1.87B	$3.31B	N/A	16,000	Earnings Report High Trading Volume
ADUS Addus HomeCare	4.4467 of 5 stars	$100.12 +0.6%	$133.22 +33.1%	-10.2%	$1.86B	$1.42B	19.22	50,659	Earnings Report
AHCO AdaptHealth	4.5985 of 5 stars	$13.04 -1.0%	$13.00 -0.3%	+31.9%	$1.79B	$3.24B	N/A	10,900	News Coverage Earnings Report Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AGL) was last updated on 5/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilon Health (AGL) Competitors

AGL vs. WGS, SGRY, ADUS, AHCO, and SNDA

How does Agilon Health compare to GeneDx?

Summary

How does Agilon Health compare to Surgery Partners?

Summary

How does Agilon Health compare to Addus HomeCare?

Summary

How does Agilon Health compare to AdaptHealth?

Summary

How does Agilon Health compare to Sonida Senior Living?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilon Health (AGL) Competitors

AGL vs. WGS, SGRY, ADUS, AHCO, and SNDA

How does Agilon Health compare to GeneDx?

Is WGS or AGL more profitable?

Do analysts prefer WGS or AGL?

Do institutionals & insiders have more ownership in WGS or AGL?

Which has higher earnings & valuation, WGS or AGL?

Does the media prefer WGS or AGL?

Which has more risk and volatility, WGS or AGL?

Summary

How does Agilon Health compare to Surgery Partners?

Is AGL or SGRY more profitable?

Which has preferable valuation & earnings, AGL or SGRY?

Does the media prefer AGL or SGRY?

Do analysts rate AGL or SGRY?

Which has more risk and volatility, AGL or SGRY?

Summary

How does Agilon Health compare to Addus HomeCare?

Do institutionals and insiders have more ownership in ADUS or AGL?

Is ADUS or AGL more profitable?

Which has higher valuation & earnings, ADUS or AGL?

Does the media refer more to ADUS or AGL?

Do analysts prefer ADUS or AGL?

Which has more risk & volatility, ADUS or AGL?

Summary

How does Agilon Health compare to AdaptHealth?

Is AHCO or AGL more profitable?

Which has stronger valuation and earnings, AHCO or AGL?

Do insiders & institutionals hold more shares of AHCO or AGL?

Does the media prefer AHCO or AGL?

Do analysts prefer AHCO or AGL?

Which has more volatility and risk, AHCO or AGL?

Summary

How does Agilon Health compare to Sonida Senior Living?

Which has stronger valuation and earnings, SNDA or AGL?

Which has more volatility and risk, SNDA or AGL?

Does the media prefer SNDA or AGL?

Do insiders & institutionals hold more shares of SNDA or AGL?

Do analysts prefer SNDA or AGL?

Is SNDA or AGL more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGL vs. The Competition

Agilon Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools